Biogen (BIIB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist

158.345
+2.345+1.50%

Trading Nov 21 15:23 ET

23.07BMarket Cap14.32P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Optimism Over Global Healthcare Sector Rises: Jefferies
Seeking Alpha13:45 ET
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Kevin TraversNov 21 10:53 ET
Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207
BenzingaNov 21 08:08 ET · Ratings
Biogen Analyst Ratings
BenzingaNov 21 08:07 ET · Ratings
Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $207
Moomoo NewsNov 21 07:31 ET · Ratings
European Commission Approves Samsung Bioepis, Biogen's Biosimilar Opuviz
MT NewswiresNov 20 23:07 ET

Comments

J-Eazy

Nov 15 13:08

garabage

this stock is 🗑️
$Biogen (BIIB.US)$

QMengColdJoke

Nov 14 10:04

? you just saved world?

$Biogen (BIIB.US)$

Movers and Shakers

Oct 30 07:28

Columns Today's Pre-Market Movers and Top Ratings | GOOGL, AMD, V, LLY and More

Morning Movers
Gapping up
$Alphabet-A (GOOGL.US)$ stock rose 6.3% following third-quarter results that exceeded expectations, with a notable increase in advertising revenue, which alleviated concerns over competition from AI-driven search products.
$Biogen (BIIB.US)$ stock increased 1.2% after the biotech company raised its annual earnings forecast and reported third-quarter earnings that surpassed both top and bottom line expe...

Movers and Shakers

Aug 1 07:27

Columns Today's Morning Movers and Top Ratings: META, ARM, MRNA, SHAK and More

Morning Movers
Gapping up
$Meta Platforms (META.US)$ stock rose 8.9% following stronger-than-expected second-quarter earnings and a positive future outlook.
$ConocoPhillips (COP.US)$ stock increased by 0.8% after reporting a second-quarter profit that surpassed estimates, aided by higher output and oil prices.
$Ferrari (RACE.US)$ stock climbed 3.3% as the company raised its full-year revenue and core earnings forecasts, having ex...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Investment Theme

Cancer Research

Intraday+1.13%

BIIB Biogen

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target